The new moleculary targeted drug for the treatment of non small cell lung cancer (NSCLC)

Abstract

Author presented recent study results from ELCO-ESMO conference in 2011. Crizotinib was evaluated as effective and safedrug in NSCLC patients bearing breaks of gene ALK.

Keywords

• new
• moleculary
• targeted
• drug
• for
• treatment
• non
• small
• cell
• lung
• cancer
• NSCLC